The age-dependent risk of postvaccination complications in vaccinees with smallpox vaccine
- PMID: 1347190
- DOI: 10.1016/0264-410x(92)90023-d
The age-dependent risk of postvaccination complications in vaccinees with smallpox vaccine
Abstract
The use of vaccinia virus in recombinant systems may result in the occurrence of complications observed following smallpox vaccination. The results are presented of a large survey carried out in the USSR between 1968 and 1979. High complication rates are reported, particularly in older primary vaccinees; for example, there were 312.5 cases of neurological complications per million in those aged greater than or equal to 5 years. The author concludes that this factor will limit the use of vaccinia virus in recombinant technology.
Similar articles
-
[Clinico-pathogenetic grouping of postvaccinal reactions and complications following smallpox vaccination].Vopr Okhr Materin Det. 1971 Aug;16(8):15-8. Vopr Okhr Materin Det. 1971. PMID: 4402961 Russian. No abstract available.
-
Smallpox vaccination and adverse reactions. Guidance for clinicians.MMWR Recomm Rep. 2003 Feb 21;52(RR-4):1-28. MMWR Recomm Rep. 2003. PMID: 12617510
-
[Pathogenesis of postvaccinal complications on the part of the central nervous system following smallpox vaccination in children].Zh Nevropatol Psikhiatr Im S S Korsakova. 1969;69(10):1484-7. Zh Nevropatol Psikhiatr Im S S Korsakova. 1969. PMID: 4189924 Russian. No abstract available.
-
[Side reaction following smallpox vaccination].Nihon Rinsho. 1971;29(4):1166-71. Nihon Rinsho. 1971. PMID: 4102940 Review. Japanese. No abstract available.
-
Adverse events occurring after smallpox vaccination.Semin Pediatr Infect Dis. 2003 Jul;14(3):189-95. doi: 10.1016/s1045-1870(03)00032-3. Semin Pediatr Infect Dis. 2003. PMID: 12913830 Review.
Cited by
-
Swinepox virus as a vaccine vector for swine pathogens.Adv Vet Med. 1999;41:463-80. doi: 10.1016/s0065-3519(99)80035-4. Adv Vet Med. 1999. PMID: 9890036 Free PMC article. Review.
-
Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection.J Virol. 1992 Dec;66(12):7067-72. doi: 10.1128/JVI.66.12.7067-7072.1992. J Virol. 1992. PMID: 1331509 Free PMC article.
-
Frequency of adverse events after vaccination with different vaccinia strains.PLoS Med. 2006 Aug;3(8):e272. doi: 10.1371/journal.pmed.0030272. PLoS Med. 2006. PMID: 16933957 Free PMC article.
-
Comparing New-Generation Candidate Vaccines against Human Orthopoxvirus Infections.Acta Naturae. 2017 Apr-Jun;9(2):88-93. Acta Naturae. 2017. PMID: 28740731 Free PMC article.
-
Protective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated cytotoxic T lymphocyte epitopes in a string-of-beads fashion.Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14660-5. doi: 10.1073/pnas.94.26.14660. Proc Natl Acad Sci U S A. 1997. PMID: 9405669 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical